文献速递胸部肿瘤放疗

接受根治性常规放疗的非小细胞肺癌患者新发心房颤动的预测

Prediction of new-onset atrial fibrillation in patients with non-small cell lung cancer treated with curative-intent conventional radiotherapy.
PubMed 文献 · Radiother Oncol · 2024-09-26

本研究纳入374例接受根治性常规光子放疗的I-IV期非小细胞肺癌患者,通过对比基线与随访心电图识别新发心房颤动,并构建预测模型。42例(11.2%)患者出现新发心房颤动,模型基于年龄、超重或肥胖、饮酒、心脏操作史、上叶肿瘤、FEV1、肌酐、同步化疗及左心房Dmax等预测因子,曲线下面积0.80(95%CI 0.76-0.84),校正和净获益良好。该模型可用于识别高危患者,以考虑主动筛查和及时管理。

要点

  • 374例接受根治性常规光子放疗的I-IV期非小细胞肺癌患者中,42例(11.2%)出现新发心房颤动。
  • 预测因子包括年龄、超重或肥胖、饮酒、心脏操作史、上叶肿瘤、FEV1、肌酐、同步化疗及左心房Dmax。
  • 模型曲线下面积0.80(95%CI 0.76-0.84),校正和净获益良好,可用于识别高危患者。

核心结论

  • 该预测模型利用易于获取的预测因子识别新发心房颤动高危患者,这些患者可能从放疗后心房颤动的主动筛查和及时管理中获益。

研究设计与样本

  • 纳入I-IV期非小细胞肺癌患者,接受根治性常规光子放疗(单纯放疗或多模式治疗的一部分)。
  • 通过对比基线心电图与随访心电图识别新发心房颤动。
  • 考虑多种临床预测因子及全心和六个自动勾画的心脏亚结构(包括心腔和传导节点)的剂量体积参数进行统计建模,并进行乐观校正的内部验证,构建列线图。

主要发现

  • 共纳入374例患者(平均年龄69±10岁,57%为男性),基线时9.1%的患者有心房颤动,42例(11.2%)患者出现新发心房颤动。
  • 预测因子包括:年龄较大(OR=1.04,95%CI 1.013-1.068)、超重或肥胖(OR=1.791,95%CI 1.139-2.816)、饮酒(OR=4.052,95%CI 2.445-6.715)、心脏操作史(OR=2.329,95%CI 1.287-4.215)、肿瘤位于上叶(OR=2.571,95%CI 1.518-4.355)、较高的第1秒用力呼气容积(OR=0.989,95%CI 0.979-0.999)、较高的肌酐(OR=1.008,95%CI 1.002-1.014)、同步化疗(OR=3.266,95%CI 1.757-6.07)及左心房Dmax(OR=1.022,95%CI 1.012-1.032)。
  • 模型显示出良好的区分度(曲线下面积=0.80,95%CI 0.76-0.84)、校准和正向净获益。

关键数值与推荐

  • 新发心房颤动的预测因子及对应OR值:年龄较大OR=1.04(95%CI 1.013-1.068)、超重或肥胖OR=1.791(95%CI 1.139-2.816)、饮酒OR=4.052(95%CI 2.445-6.715)、心脏操作史OR=2.329(95%CI 1.287-4.215)、上叶肿瘤OR=2.571(95%CI 1.518-4.355)、较高的第1秒用力呼气容积OR=0.989(95%CI 0.979-0.999)、较高的肌酐OR=1.008(95%CI 1.002-1.014)、同步化疗OR=3.266(95%CI 1.757-6.07)、左心房Dmax OR=1.022(95%CI 1.012-1.032)。
  • 模型区分度:曲线下面积=0.80(95%CI 0.76-0.84)。

临床怎么用

  • 作者认为,该预测模型利用易于获取的预测因子识别新发心房颤动高危患者,这些患者可能从放疗后心房颤动的主动筛查和及时管理中获益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Atrial fibrillation (AF) is an important side effect of thoracic Radiotherapy (RT), which may impair quality of life and survival. This study aimed to develop a prediction model for new-onset AF in patients with Non-Small Cell Lung Cancer (NSCLC) receiving RT alone or as a part of their multi-modal treatment. PATIENTS AND METHODS: Patients with stage I-IV NSCLC treated with curative-intent conventional photon RT were included. The baseline electrocardiogram (ECG) was compared with follow-up ECGs to identify the occurrence of new-onset AF. A wide range of potential clinical predictors and dose-volume measures on the whole heart and six automatically contoured cardiac substructures, including chambers and conduction nodes, were considered for statistical modeling. Internal validation with optimism-correction was performed. A nomogram was made. RESULTS: 374 patients (mean age 69 ± 10 years, 57 % male) were included. At baseline, 9.1 % of patients had AF, and 42 (11.2 %) patients developed new-onset AF. The following parameters were predictive: older age (OR=1.04, 95 % CI: 1.013-1.068), being overweight or obese (OR=1.791, 95 % CI: 1.139-2.816), alcohol use (OR=4.052, 95 % CI: 2.445-6.715), history of cardiac procedures (OR=2.329, 95 % CI: 1.287-4.215), tumor located in the upper lobe (OR=2.571, 95 % CI: 1.518-4.355), higher forced expiratory volume in 1 s (OR=0.989, 95 % CI: 0.979-0.999), higher creatinine (OR=1.008, 95 % CI: 1.002-1.014), concurrent chemotherapy (OR=3.266, 95 % CI: 1.757 to 6.07) and left atrium Dmax (OR=1.022, 95 % CI: 1.012-1.032). The model showed good discrimination (area under the curve = 0.80, 95 % CI: 0.76-0.84), calibration and positive net benefits. CONCLUSION: This prediction model employs readily available predictors to identify patients at high risk of new-onset AF who could potentially benefit from active screening and timely management of post-RT AF.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Tohidinezhad F, Nürnberg L, Vaassen F, et al. Prediction of new-onset atrial fibrillation in patients with non-small cell lung cancer treated with curative-intent conventional radiotherapy. Radiother Oncol. 2024. PMID: 39341504. doi:10.1016/j.radonc.2024.110544

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。